Patents/Assignees

Newave Pharmaceutical Inc.

9 patents in portfolio

US12583853utility2026
1h-pyrrolo[2,3-b]pyridine Derivatives and Related Compounds as BCL-2 Inhibitors for the Treatment of Neoplastic and Autoimmune Diseases
0 cites
US12569564utility2026
Spirocyclic MDM2 Modulator and Uses Thereof
0 cites
US12552784utility2026
1h-pyrrolo[2,3-b]pyridine Derivatives as BCL-2 Inhibitors for the Treatment of Neoplastic and Autoimmune Diseases
0 cites
US12410190utility2025
Condensed Heterocyclic Derivates as BCL-2 Inhibitors for the Treatment of Neoplastic Diseases
0 cites
US12220419utility2025
BCL-2 Inhibitors
0 cites
US12086788utility2024
Substituted Pyrazines as Inhibitors of BTK, and Mutants Thereof
0 cites
US11993610utility2024
BCL-2 Inhibitors
0 cites
US11903950utility2024
BCL-2 Inhibitors
0 cites
US11680072utility2023
Condensed Heterocyclic Derivates as BCL-2 Inhibitors for the Treatment of Neoplastic Diseases
0 cites